Back to Search
Start Over
CRISPR-Cas13: A new frontier in RNA-editing with revolutionary therapeutic potential
- Source :
- Medical Letter on the CDC & FDA. October 13, 2024, p683.
- Publication Year :
- 2024
-
Abstract
- 2024 OCT 13 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- In recent years, the scientific community has made significant strides [...]
Details
- Language :
- English
- ISSN :
- 15324648
- Database :
- Gale General OneFile
- Journal :
- Medical Letter on the CDC & FDA
- Publication Type :
- News
- Accession number :
- edsgcl.811289992